Skip to main content

INDOCO · Indoco Remedies Limited · Financials

228.30 INR +0.05 (+0.02%) At close · Nov 13
Volume · Nov 13 2889 Avg daily vol (14 sessions) 11.45K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
18.45B +10.8%
FY2026 Revenue FY2020–FY2026
Net Income
-951.5M -29%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
1.92B +102.5%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 19.09B 18.45B 16.65B 18.17B 16.69B 15.41B 12.42B 11.07B
INR 1.33B 1.26B 1.14B 918.7M 706.1M 789.6M 731.3M 708.2M
INR 1.27B 1.22B 662.3M 380.2M 250.3M 141.4M 222.6M 262.5M
INR 456M -1.07B -743.7M 1.36B 1.93B 2.37B 1.32B 285.8M
INR 138.2M -78.1M 35.8M 387.9M 505.5M 817.7M 389.5M 44.6M
INR 319.4M -951.5M -737.4M 984.7M 1.42B 1.55B 0 241.2M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 710.3M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.